Association between a nurse-led advocacy model and treatment adherence among patients with pulmonary Tuberculosis: a non-randomized controlled trial in Zhejiang Province, China
Year: 2026
Type: article
Study design: Clinical Trial
Abstract: Background Systemic barriers and patient-centered monitoring deficits often undermine tuberculosis (TB) treatment adherence in urban environments, escalating the risk of clinical attrition and multidrug resistance. This study evaluated the association between an integrated Nurse-Led Advocacy Model (NLAM) and therapeutic adherence among patients with pulmonary TB within Zhejiang Province, China.Methods A non-randomized controlled trial was conducted across municipal clinics in Shaoxing, Zhejiang, between August 17, 2023, to August 1, 2025. Following propensity score matching via a 1:1 nearest-neighbor algorithm to eliminate baseline imbalances, 300 patients were evaluated: 152 in the NLAM cohort (received structured, face-to-face advocacy sessions spanning intensive and continuation phases with digital adherence technology (DAT) consisting of an electronic smart pill box and the WeChat-TB mini-program interface and 148 in the routine clinical care (RCC cohort; received standard institutional treatment monitoring).Results Baseline demographic profiles and clinical characteristics were highly balanced between groups (p > 0.05). The NLAM cohort exhibited significantly higher medication adherence across both drug-susceptible (mean ± SD: 94.5% ± 2.6% vs. 82.8% ± 2.9%; p < 0.001) and multidrug-resistant strains (90.9% ± 2.1% vs. 72.3% ± 2.1%; p < 0.001) compared to the RCC group. Longitudinal survival analysis showed a significantly lower rate of cumulative clinical attrition under the advocacy framework (5.3% [8/152] vs. 14.9% [22/148] loss to follow-up events; Relative Risk = 0.35, 95% Confidence Interval: 0.16–0.77; Log-rank p < 0.001). Patient-perceived nursing support based on the Nursing Advocacy Scale was remarkably higher in the NLAM cohort (p < 0.001).Conclusion Structured nurse-led advocacy framework coupled with smart-box digital monitoring is strongly associated with optimized medication adherence, heightened patient-perceived support, and minimized clinical attrition.
Source: Annals of Medicine
Authors: Jianying Cai(Conceptualization, Methodology, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing), Zunyou Ke(Investigation, Methodology, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing), Yinna Yao(Data curation, Formal analysis, Project administration, Resources, Writing – original draft, Writing – review & editing), Weiwei Chen(Conceptualization, Investigation, Software, Validation, Writing – original draft, Writing – review & editing)
Institution: Shaoxing University
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,557
Funder: Shaoxing University
OpenAlex ID: W7236127838
